Parx antibacterial technology applied to mask protective clothing
At the beginning of 2020, the new crown virus epidemic broke out and spread around the world. According to WHO data, a large number of people were infected with new crown pneumonia. The supply of medical supplies and protective equipment with quality and quantity is an important factor in winning the battle against the epidemic. Medical protective clothing and masks are mainly used for medical staff to wear, which can effectively block microorganisms, block the penetration of body fluids, and prevent disease transmission.
Medical protective clothing is specially used in the medical and health industry. It is suitable for providing barriers for medical staff to contact potentially infectious patients' blood, body fluids, secretions, germs, harmful ultrafine dust, acidic solutions, salt solutions, and to keep the environment clean while working. , Special protective clothing for protection. Medical protective clothing is the most basic part of medical protective equipment, and the protective performance and test indicators of protective clothing are particularly important.
Hospital infections are a global problem
In China, the incidence of nosocomial infections is about 2% to 2.7%. According to related literature, the prevalence rate in the United States during the same period is about 3.2 to 4%, and that in Europe is 5.9%. The objects of nosocomial infection include inpatients, hospital staff, patients in outpatient and emergency departments, visitors and family members of patients. When the defense function of the whole body or the local respiratory tract is reduced, the viruses or bacteria that have existed in the upper respiratory tract or invaded from the outside can multiply rapidly. Parx technology is integrated into the product at the time of production to inhibit the growth of harmful organisms in the healthcare environment.
Parx can achieve 99.9% antibacterial efficiency and broad-spectrum sterilization
Parx technology is integrated into the product at the time of production to inhibit the growth of harmful microorganisms in the medical environment. In laboratory research, Parx's customized antibacterial technology for healthcare equipment has been verified, which can reduce oxycillin-resistant Staphylococcus aureus (MRSA), Escherichia coli and other bacteria by up to 99.9%, and has a broad-spectrum sterilization effect. Antimicrobial products used in healthcare benefit from the additional protection provided by integrated technology. Even after repeated contamination, these products maintain a high level of hygiene after cleaning and reduce the spread of bacteria on high-contact surfaces. Because technology is integrated into the product when it is produced, these technologies become part of the product and will not be lost or worn out.
● By changing the mechanical and physical properties, continuous antibacterial properties are produced inside and on the surface of the material without precipitation. The antibacterial properties are synchronized with the product life cycle and will not decay over time.
● Masks and protective clothing using Parx technology can effectively prevent the adhesion and reproduction of bacteria and biofilms, and reduce the risk of secondary pollution of medical waste.
● According to the ISO22196 standard and the testing data of many third-party independent laboratories in the world, products containing Parx antibacterial technology can achieve broad-spectrum sterilization, with an antibacterial efficiency of 99.9% or higher.
● Parx technology effectively reduces the risk and probability of infection of the user, and eliminates the odor and peculiar smell generated by the exhaled breath on the mask. Skin-friendly and non-irritating, suitable for people with sensitive skin.
Hospital beds use antibacterial acrylic resin (PMMA)
Fight antibiotic resistance in the right way
The technology developed by Parx Meterials is derived from nature's antibacterial principles. The discoveries and inventions made in the research are truly unique and groundbreaking. After more than four years of focusing on bionics research, the bionics method has been adopted in the design and production of materials to create a safe and biocompatible technology to inhibit the growth of bacteria on the plastic surface. It has realized global plastic patent innovation, and the effective rate of antibacterial/antimicrobial is as high as 99%. This is a technology copied from nature, and the most important thing is safety.
A technology copied from nature that makes bacteria unable to resist
The method of incorporating this high-efficiency antibacterial property into plastic does not use any harmful substances, does not change the original characteristics of the material, and does not require migration. So no substance is leached from the material. The combination of plastic and biocompatibility solutions makes materials and surfaces more resistant to attack by microorganisms and bacteria. The growth and proliferation of bacteria on the surface of the object slows down. According to the ISO22196 standard, the number of microorganisms and bacteria is greatly reduced by 99%.
The antibacterial properties are only due to the (changed) mechanical/physical properties of the surface, not due to migration. Bacteria cannot grow and proliferate on the surface of the material, nor do they contain toxins or biocides (this may lead to the formation of antibiotic resistance). A truly safe solution comes from nature.
